Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Pulmonology Congress 2020

About conference

Asia Pacific Conferences heartily welcomes you to the most prestigious International Congress and Expo on Pulmonology during October 19-20, 2020 Manila, Philippines. The pulmonology Conference is based on the theme “Advance Research of Respirology and Chest’’

Conference welcomes pulmonology and Respiratory specialists across the globe to discuss current trends in respiratory disease screening to diagnosis, treatment and management .strategic sessions of the pulmonary & Respiratory covering about almost all of the pulmonology  Diseases such as COPD, Asthma, Allergy, Cystic fibrosis, pneumonia, tuberculosis, emphysema, Lung nodules, chronic cough ,mycobacterial infection ,influenza ,Bronchiectasis, etc.

The pulmonology congress conference  composed of well –organized scientific sessions ,plenary sessions, oral presentation, poster presentation , one to one meetings ,networking sessions, e-poster presentation ,young Research Forums ,B2B meetings ,international workshops ,symposiums, Industrial  sessions, Exhibitor presentation etc.

Who Should Attend?

Pulmonology congress 2020 welcomes the multidisciplinary medical professionals, clinicians, and researchers associated with the diagnosis, treatment associated with the diagnosis, treatment and management of respiratory diseases and allied fields. This pulmonology congress is the best platform that would help the pulmonologists and Respiratory care professionals to get the insights and latest trends to improve the patient care. All the researchers working in the field of Pulmonology, Respiratory Medicine, Asthma, Pneumonia, emphysema, tuberculosis, COPD, lungs diseases, Lung Cancer, complicated chest infections and other allied fields will be of interest. The Scope of this Pulmonology Conference is for the below professionals, but not limited to:

  • Pulmonologists
  • Respiratory medicine
  • Respiratory physicians
  • Respiratory disease specialists
  • Allergy and Immunology
  • General Medicine & Internal Medicine
  • Respiratory Therapy
  • Radiology & Radiotherapy
  • Physiotherapy
  • Nursing
  • Behavioral Science
  • Environmental and Occupational Health
  • Infectious Disease
  • Pediatric Pulmonary, Critical Care and Sleep
  • Cardiology

By attending the Pulmonology congress 2020, Manila, Philippines can get the insights of:

  • Recent trends & techniques of pulmonology medicine
  • Upgrade yourself with latest innovations to optimize the treatment process of pulmonology Diseases
  • Discuss the current challenges & update with future opportunities in improving respiratory care in future era
  • Assess the treatment gaps of various pulmonary & Respiratory diseases
  • Update yourself with new strategies of diagnosing Sleep Apnea, Asthma, Allergy, COPD and other related diseases and define the new treatment strategies
  • Review the efficacy of spirometer access of breathing partten and to identify various disease conditions like Asthma, COPD, pulmonary fibrosis, cystic fibrosis and to optimize the non-invasive mechanical ventilation process in case of respiratory failure.

Abstract Eligibility Criteria

AUTHOR ELIGIBILITY:

  • Individuals may submit up to two regular abstracts as the first author.
  • Individuals may submit an unlimited number of Trials in Progress abstracts.
  • Individuals may serve as a co-author on an unlimited number of abstracts.

ABSTRACT ELIGIBILITY

  • All types of Pulmonologists, Thoracic Surgeon’s, Medicinal, Health research are eligible for submission.
  • Abstract should address scientific questions, detail clinical observations, or contain primary scientific data.
  • Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown.
  • Interim analysis of a prospective randomized clinical trial will be considered if it is performed as planned in the original protocol and is statistically valid.
  • Abstracts of clinically-related subjects should be combined into a single abstract.

Note: Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.

Submission Requirements:

Provide your full name, academic degree(s), institution, address, and email address and recent photograph. You will receive all future correspondence from us regarding the status of your abstract.

The selected abstracts will be published in Conference Proceedings.

Important Dates:

Early Bird Discount Registration Offer: On/Before January 30, 2020

Early Bird Abstract Submission Date: February 25, 2019

Abstract Submission Deadline: March 15, 2020

Speaker Presentations Sessions and Time limits:

Keynote Speech 40-45 Minutes,

Workshop/Symposium 60 Minutes

Plenary Speech 20-25 Minutes,

Poster Presentation 10-15 Minutes

 

Sessions/ Tracks

Track 01 : Pulmonary Hypertension

Pulmonary hypertension is a type of high blood pressure that affects the arteries in lungs and the right side of heart. In one form of pulmonary hypertension, tiny arteries in lungs, called pulmonary arterioles, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through lungs, and raises pressure within lungs' arteries. As the pressure builds, the heart's lower right chamber (right ventricle) must work harder to pump blood through the lungs, eventually causing heart muscle to weaken and fail

Each form of Pulmonary hypertension is different, so it is important for newly-diagnosed patients to find a Pulmonary hypertension specialist who can accurately find what is causing their Pulmonary hypertension and develop a treatment plan that is right for that specific type of Pulmonary hypertension as soon as possible. Every person with pulmonary hypertension is different, and new research is being conducted every day with the potential to improve the outlook for people living with this disease. Once in the care of a pulmonary hypertension treating health care team and on appropriate therapy, people with pulmonary hypertension can live many years.

Track 2: Chronic Obstructive Pulmonary Disease

Chronic obstructive Pulmonary Disease is a constant incendiary lung illness that causes discouraged wind stream from the lungs. Side effects incorporate breathing trouble, hack, bodily fluid creation and wheezing. It's brought about by long haul introduction to disturbing gases or particulate issue, frequently from tobacco smoke. Individuals with COPD are at expanded danger of creating coronary illness, lung malignancy and an assortment of different conditions. The top reason for COPD is tobacco smoking. Long haul introduction to synthetic aggravations can likewise prompt COPD. It's a sickness that generally sets aside a long effort to create

Diagnosis usually involves imaging tests, blood tests, and lung function tests. There's no solution for COPD, yet treatment can help ease manifestations, bring down the opportunity of intricacies, and for the most part improve personal satisfaction. Meds, supplemental oxygen treatment, and medical procedure are a few types of treatment. Early indications incorporate into COPD are incidental brevity of breath, particularly after exercise, mellow however repetitive hack and expecting to make a sound as if to speak regularly, particularly before anything else.

Track 3 : Pulmonary Rehabilitation

Pulmonary rehabilitation  also known as respiratory rehabilitation is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is defined by the American Thoracic Society and the European Respiratory Society as an evidence-based, multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. In general, pulmonary rehabilitation refers to a series of services that are administered to patients of respiratory disease and their families, typically to attempt to improve the quality of life for the patient.

Pulmonary rehabilitation may be carried out in a variety of settings, depending on the patient's needs, and may or may not include pharmacologic intervention. Pulmonary rehabilitation is generally specific to the individual patient, with the objective of meeting the needs of the patient. It is a broad program and may benefit patients with lung diseases such as chronic obstructive pulmonary disease (COPD), sarcoidosis, idiopathic pulmonary fibrosis (IPF) and cystic fibrosis, among others. Although the process is focused on the rehabilitation of the patient him/herself, the family is also involved. The process typically does not begin until a medical exam of the patient has been performed by a licensed physician.

Track 4: Asthma and Allergy

Allergic asthma is asthma caused by an allergic reaction. It’s also known as allergy-induced asthma. People with allergic asthma usually start feeling symptoms after inhaling an allergen such as pollen. The Asthma and Allergy Foundation of America reports that more than half of people with asthma have allergic asthma. Allergic asthma is treatable in most cases. An allergen is a typically harmless substance such as dust mites, pet dander, pollen or mold. If you are allergic to a substance, this allergen triggers a response starting in the immune system. Through a complex reaction, these allergens then cause the passages in the airways of the lungs to become inflamed and swollen. This results in coughing, wheezing and other asthma symptoms

The same allergens that give some people sneezing fits and watery eyes can cause an asthma attack in others. Allergic asthma is the most common type of asthma. About 90% of kids with childhood asthma have allergies, compared with about 50% of adults with asthma. The symptoms that go along with allergic asthma show up after you breathe things called allergens like pollen, dust mites, or mold. If you have asthma it usually gets worse after you exercise in cold air or after breathing smoke, dust, or fumes. Sometimes even a strong smell can set it off.

Track 5: Tuberculosis

Tuberculosis is s transferable infection that usually attacks the lungs. It can also spread to other parts of the body, like the brain and spine. A type of bacteria called Mycobacterium tuberculosis causes it. The classic symptoms of active TB are a chronic cough with blood-containing mucus, fever, night sweats, and weight loss. It was historically called "consumption" due to the weight loss. Infection of other organs can cause a wide range of symptoms. Tuberculosis is spread through the air when people who have active TB in their lungs cough, spit, speak, or sneeze. Active infection occurs more often in people with HIV/AIDS and in those who smoke. Diagnosis of active TB is based on chest X-rays, as well as microscopic examination and culture of body fluids. Diagnosis of latent TB relies on the tuberculin skin test (TST) or blood tests

Prevention of TB involves screening those at high risk, early detection and treatment of cases, and vaccination with the bacillus Calmette-Guérin (BCG) vaccine. Those at high risk include household, workplace, and social contacts of people with active TB. Treatment requires the use of multiple antibiotics over a long period of time.  Antibiotic resistance is a growing problem with increasing rates of multiple drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).

Track 6: Cardio Pulmonary Disorders

Cardiopulmonary disease is the medical term used to describe a range of serious disorders that affect the heart and lungs. The two primary tobacco-related cardiopulmonary diseases are Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD). Exposure to tobacco smoke has long been recognized as a prominent risk factor for CVD. Similarly minimizing exposure to tobacco smoke is the only effective way to prevent COPD. However, the mechanisms by which tobacco toxicants increase the risk of CVD and lead to the onset of COPD are still unclear. Despite reductions in smoking over the past decade, CVD and COPD remain the first and second leading causes of death among smokers. It is important to remember also that for every person who dies because of smoking; at least 30 people live with a serious smoking-related illness.

The emergence of e-cigarettes and other new tobacco products that deliver nicotine aerosolized in various solvents raises new critical questions regarding the potential risk for cardiopulmonary disease among users. The use of these new tobacco products has soared over the last few years, particularly among adolescents, and is expected to overtake the conventional cigarette market within the next decade. These new products deliver nicotine and chemical flavorings aerosolized in a base of propylene glycol and/or glycerin via inhalation.

Track 7: Pulmonary diseases: Treatment, Diagnosis and therapies

Diagnosis:
1. Spirometer is a noninvasive test to assess lung function. During the test, you’ll take a deep breath and then blow into a tube connected to the spirometer.
2. Imaging tests include a chest X-ray or CT scan. These images can provide a detailed look at your lungs, blood vessels, and heart.
3. An arterial blood gas test involves taking a blood sample from an artery to measure blood oxygen, carbon dioxide, and other important levels.
Treatment:
Smoking cessationThe most essential step in any treatment plan for COPD is to stop all smoking. It's the only way to keep COPD from getting defective which can eventually reduce ability to breathe.
Bronchodilators: These medications which usually come in an inhaler relax the muscles around airways. This can help relieve coughing and shortness of breath and make breathing easier.
Inhaled steroids: Inhaled corticosteroid medications can reduce airway inflammation and help prevent exacerbations. Side effects may include bruising, oral infections and hoarseness. These medications are useful for people with frequent exacerbations of COPD.
Phosphodiesterase-4 inhibitors: A new type of medication approved for people with severe COPD and symptoms of chronic bronchitis is roflumilast a phosphodiesterase-4 inhibitor. This drug decreases airway inflammation and relaxes the airways.
Antibiotics: Respiratory infections, such as acute bronchitis, pneumonia and influenza, can aggravate COPD symptoms. Antibiotics help treat acute exacerbations, but they aren't generally recommended for prevention.
Therapies:
Oxygen therapy: There are several devices to deliver oxygen to the lungs, including lightweight, portable units that you can take with you to run errands and get around town. Some people with COPD use oxygen only during activities or while sleeping. Others use oxygen all the time. Oxygen therapy can improve quality of life and is the only COPD therapy proven to extend life
pulmonary rehabilitation program: These programs generally combine education, exercise training, nutrition advice and counseling.  Pulmonary rehabilitation may shorten hospitalizations, increase your ability to participate in everyday activities and improve your quality of life.

Track 8: Lung cancer

Lung cancer is a condition that causes cells to divide in the lungs uncontrollably. This causes the growth of tumors that reduce a person's ability to breathe. In lung cancer, this pattern of cell overgrowth occurs in the lungs, which are vital organs for breathing and gas exchange. Cigarette smoking is the principal risk factor for development of lung cancer, Passive exposure to tobacco smoke (passive smoking) also can cause lung cancer in non-smokers. The two types of lung cancer, which grow and spread differently, are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Medical professionals also refer to them as small-cell lung carcinoma and non q-small-cell lung carcinoma.

The stage of lung cancer refers to the extent to which the cancer has spread in the body. Treatment of lung cancer can involve a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy as well as newer experimental methods. The general prognosis of lung cancer is poor because doctors tend not to find the disease until it is at an advanced stage. Five-year survival is around 54% for early stage lung cancer patients that have a tumor localized to the lungs, but only around 4% in those with advanced, inoperable lung cancer. Smoking cessation is the most important measure that can prevent the development of lung cancer

Track 9: Pulmonary Hypertension

Pulmonary hypertension is a type of high blood pressure that affects the arteries in lungs and the right side of heart. In one form of pulmonary hypertension, tiny arteries in lungs, called pulmonary arterioles, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through lungs, and raises pressure within lungs' arteries. As the pressure builds, the heart's lower right chamber (right ventricle) must work harder to pump blood through the lungs, eventually causing heart muscle to weaken and fail

Each form of Pulmonary hypertension is different, so it is important for newly-diagnosed patients to find a Pulmonary hypertension specialist who can accurately find what is causing their Pulmonary hypertension and develop a treatment plan that is right for that specific type of Pulmonary hypertension as soon as possible. Every person with pulmonary hypertension is different, and new research is being conducted every day with the potential to improve the outlook for people living with this disease. Once in the care of a pulmonary hypertension treating health care team and on appropriate therapy, people with pulmonary hypertension can live many years.

Track 10:Pediatric Pulmonology & Critical care

Respiratory implies the field of drug identifying with lung and respiratory issue. Working with general pediatrics, aspiratory pediatricians treat an extensive variety of pneumonic issue. Respiratory implies the field of solution identifying with lung and respiratory issue. Working with general pediatrics, aspiratory pediatricians treat an extensive variety of pneumonic issue. It incorporates Asthma, Sleep Disorder, Chronic Cough, Exercise initiated Asthma, Congenital Lung Problem and Pediatric Pneumonia.

A great part of the focal point of aspiratory recovery, look into and pneumonic solution goes toward the most youthful individuals from society-the babies. It's inherent however treatable. With a sound aspiratory stenosis finding the heart valve can be supplanted or repaired and kids can develop to lead ordinary solid lives. Rest apnea influences untimely infants. A circumstance called apnea of rashness exists when the tyke doesn't breath for 20 seconds or more. It's a pneumonic illness that can be treated with ventilation machines and medicines.

Track 11:Lung Transplantation

Lung cancer is a condition that causes cells to divide in the lungs uncontrollably. This causes the growth of tumors that reduce a person's ability to breathe. In lung cancer, this pattern of cell overgrowth occurs in the lungs, which are vital organs for breathing and gas exchange. Cigarette smoking is the principal risk factor for development of lung cancer, Passive exposure to tobacco smoke (passive smoking) also can cause lung cancer in non-smokers. The two types of lung cancer, which grow and spread differently, are small-cell lung cancers (SCLC) and non-small-cell lung cancers (NSCLC). Medical professionals also refer to them as small-cell lung carcinoma and non q-small-cell lung carcinoma.

The stage of lung cancer refers to the extent to which the cancer has spread in the body. Treatment of lung cancer can involve a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy as well as newer experimental methods. The general prognosis of lung cancer is poor because doctors tend not to find the disease until it is at an advanced stage. Five-year survival is around 54% for early stage lung cancer patients that have a tumor localized to the lungs, but only around 4% in those with advanced, inoperable lung cancer. Smoking cessation is the most important measure that can prevent the development of lung cancer

Track 12:Airway and Therapeutic Devices

Positive airway pressure (PAP) therapy is a generic term applied to all sleep apnea treatments that use a stream of compressed air to support the airway during sleep. With PAP therapy, you wear a mask during sleep. A portable machine gently blows pressurized room air from into your upper airway through a tube connected to the mask. This positive airflow helps keep the airway open, preventing the collapse that occurs during apnea, thus allowing normal breathing. For optimal improvement, it's important to use your PAP machine every time you sleep including naps. Overall PAP therapy is a safe and effective treatment; however there are a few counter-indications.

A major determining factor of upper airway patency during sleep is the activity of the genioglossus muscle. Activation of this muscle via stimulation of the hypoglossal nerve is a creative new approach for treatment of obstructive sleep apnea (OSA). Hypoglossal nerve stimulation therapy is commonly referred to as Inspire, a reference to the name of the company Inspire Medical Systems that developed the treatment, which was approved by the Food and Drug Administration in 2014

Market Analysis

The global respiratory capsules market size will develop with the aid of USD 17.Sixty seven billion for the duration of 2018-2022. This enterprise research record presents a detailed analysis of the marketplace based on kind (bronchial asthma, persistent obstructive pulmonary sickness (COPD), allergic rhinitis, cystic fibrosis, idiopathic pulmonary fibrosis, and different breathing problems.

The growth in incidences and occurrence of respiratory problems is driving worldwide respiration tablets market. Several types of breathing illnesses consisting of COPD, bronchial asthma, and acute breathing infections are at the rise causing primary mortality and disorder burden on sufferers. Moreover, respiratory sicknesses account for greater than millions of deaths in growing nations with an excessive variety of instances stated for children. This created the want for management and treatment of breathing sicknesses, which in flip, drives the respiratory pills marketplace.

Currently, North America dominates the pulmonary drug shipping devices marketplace, and Asia represents the second-biggest regional market. Moreover, the Asian market is expected to register the best CAGR during the forecast length because of the unexpectedly developing geriatric populace, growing adoption of an unhealthy lifestyle, developing urbanization, publicity to smoke & chemical compounds, and the subsequent increase in the prevalence of COPD within the place.

 

Importance & Scope:

The scope of pulmonology practice includes compounding and dispensing medications, and it also related to more modern services like patient care, including clinical services, reviewing medications for safety and efficacy, and providing drug information.

This respiratory congress is the best platform that would help the pulmonologists and respiratory care professionals to get the insights and latest trends to improve the patients care. All the researchers working in the field of Pulmonology, Respiratory Medicine, Asthma, Pneumonia, emphysema, tuberculosis, COPD, lungs diseases, Lung Cancer, complicated chest infections and other allied fields will be of interest.

Recently, Economic recession is not affected to any drug industry. This is because demand of drugs will not suppress ever. Lot of new problems regarding health and sanitation are arising day by day. Lot of work is there for pharmacist to take care of public sector.

 

 Target Audience:

  • Pulmonary drug delivery devices and formulation manufacturers
  • Public and private physicians
  • Healthcare institutions (Medical data centers)
  • Research & clinical laboratories
  • Distributors and suppliers of pulmonary drug delivery devices
  • Health insurance companies
  • Market research and consulting firms
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • CRO and DATA management Companies
  • Training Institutes
  • Business Entrepreneurs

Related Companies/Industries:

  • A Menarini Asia-Pacific Holdings Pte Ltd,
  • Ab Sciex (Distribution)
  • Abbott Laboratories (S) Pte Ltd,
  • Abbott Mfg Singapore Pte Ltd,
  • Abbvie Pte Ltd,
  • Acyx Enterprise
  • Advance Healthcare Pte Ltd,
  • Advanced Medi Mart,
  • Agila Specialties Global Pte Ltd,
  • Alcon Singapore Mfg Pte Ltd,
  • Allergen Singapore Pte Ltd,
  • Apex Pharma Marketing Pte Ltd,
  • Apotheca Marketing Pte Ltd,
  • Astonix Life Science (S) Pte Ltd,
  • Astrazeneca Singapore Pte Ltd,
  • Atlantic Pharmaceutical (S) Pte Ltd,
  • Aurum Medicare Pte Ltd,
  • Aventis Pharma Mfg Pte Ltd,
  • Ayuryoga Clinic of Ayurveda & Yoga Pte Ltd,
  • Bago Laboratories Pte Ltd,
  • Beacons Pharmaceuticals Pte Ltd,
  • Beecham Pharmaceuticals (Pte) Ltd,

Related Associations and Societies:

  • Philippine College of Chest Physicians
  • American Association for Respiratory Care
  •  Australian Lung Foundation
  •  Bangladesh Lung Foundation
  • British Thoracic Society
  • European Respiratory Society
  • Global Initiative for Obstructive Lung Disease
  • International Union Against Tuberculosis & Lung Disease
  • Korean Academy of Tuberculosis & Respiratory Diseases
  • World Association of Bronchology and Interventional Pulmonology
  • South African Thoracic Society

Past Conference Report

Pulmonary Disorders 2018

Pulmonary Disorders - 2019

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Pulmonary Disorders 2019  a wonderful event.

International Conference on Pulmonology and Critical Care Medicine was organized by Conference Series LLC, during April 24-25, 2019 in Las Vegas, USA. We successfully hosted the event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of respective Journals, scientists, researchers, as well as experts from Pulmonologist and students from diverse groups who made this conference as one of the most successful and productive events in 2019 from Conference Series LLC. It was the world’s meeting that is dedicated to Pulmonary, Heart, Critical Care and Respiratory.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note from Honourable guests and the Keynote forum lead by Dr. Shahid Sheikh, Principal Investigator, Associate, Professor Ohio State University College of Medicine USA honourable Moderator for the conference.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

·         Pulmonary Diseases and Disorders

·         Symptoms and Comorbid

·         Pulmonary Function Testing and Diagnosis

·         Asthma and Related Disorders

·         Bronchiectasis and Atelectasis

·         COPD and Related Disorders

·         Pulmonary Vascular Disease

·         Diffuse Alveolar Hemorrhage

·         Environmental Pulmonary Diseases

·         Lung Diseases

·         Pulmonary Embolism

·         Pulmonary Research

·         Pulmonary Rehabilitation

·         Critical Care Medicine

·         Novel Approach and Therapies

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Pulmonary and Critical Care, carried out through various scientific sessions and plenary lectures:

Pulmonary rehabilitation aKnde ythne ocatnec eFr osertutinmg: Is it beneficial? Is it safe? by Dr. Vickie R Shannon, The University of Texas MD Anderson Cancer Center, USA

Wheezing in Infancy. When to treat and why? by Dr. Shahid Sheikh, Ohio State University College of Medicine, USA

Respiratory management of the newborn with an Omphalocele by Dr. Joanne Baerg, Loma Linda University Medical Center, USA

The distinct roles of circulating monocytes and alveolar macrophages in mouse model with acute lung injury by Dr. Zhilong Jiang, Fudan University, PR China

The Role of Traumatic Pneumonectomy by Dr. Bradley J Phillips, Creighton University School of Medicine, USA

Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo by Dr. Donald Davidson, University of Edinburgh, UK

Difficult to Control Pediatric Asthma (co-morbidities) by Dr. Shahid Sheikh, Ohio State University College of Medicine, USA
                                                            So on…

With the unique feedbacks from the conference, Conference Series LLC announced the commencement of the 8th International Conference on Pulmonology and Critical Care Medicine

March 20 - 21, 2019 in Orlando, USA. With the support and contribution of the Organizing Committee Members, we successfully hosted the “Pulmonary Disorders 2019” at the conference venue. Hence, we look forward to see your benign presence with active contribution and support to make Pulmonary Disorders 2020successful once more.

Let us meet again @ https://pulmonologycongress.conferenceseries.com/


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date October 19-20, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Pulmonary & Respiratory Medicine Journal of Molecular Biomarkers & Diagnosis Journal of Lung Diseases & Treatment Journal of Pulmonary Medicine

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by